fetroja
(Cefiderocol sulfate tosylate)Shionogi Inc.
Usage: FETROJA® is indicated for patients aged 18 and older for treating complicated urinary tract infections (cUTIs) including pyelonephritis, and hospital-acquired/ventilator-associated bacterial pneumonia, caused by susceptible Gram-negative bacteria like E. coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa. Use should limit drug resistance.